Research Repository

Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?

Cornall, Lauren, Mathai, Michael ORCID: 0000-0001-8783-2122, Hryciw, Deanne H and McAinch, Andrew ORCID: 0000-0002-8762-4865 (2013) Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases? Expert Opinion on Investigational Drugs, 22 (4). pp. 487-498. ISSN 1354-3784 (print) 1744-7658 (online)

Full text for this resource is not available from the Research Repository.
Item Type: Article
Uncontrolled Keywords: GPR119, insulin, type 2 diabetes mellitus, metabolic disease, drug therapy, skeletal muscle, metabolism
Subjects: Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
FOR Classification > 1101 Medical Biochemistry and Metabolomics
FOR Classification > 1103 Clinical Sciences
Related URLs:
Depositing User: VUIR
Date Deposited: 30 Aug 2013 04:49
Last Modified: 10 Apr 2019 01:06
URI: http://vuir.vu.edu.au/id/eprint/21973
DOI: https://doi.org/10.1517/13543784.2013.775245
ePrint Statistics: View download statistics for this item
Citations in Scopus: 17 - View on Scopus

Repository staff only

View Item View Item

Search Google Scholar